METTL14 and hepatocellular carcinoma: For instance, the “writer” METTL14 mediates m6A-mediated EGFR methylation, thereby suppressing EGFR/PI3K/AKT activity and inhibiting epithelial–mesenchymal transition and metastasis in HCC (13).